Orion Infusions (DHA:ORIONINFU) Short-Term Debt : BDT325.4 Mil (As of Dec. 2023)

View and export this data going back to . Start your Free Trial

What is Orion Infusions Short-Term Debt?

Orion Infusions's Short-Term Debt for the quarter that ended in Dec. 2023 was BDT325.4 Mil.

Orion Infusions's quarterly Short-Term Debt declined from Jun. 2023 (BDT347.2 Mil) to Sep. 2023 (BDT336.1 Mil) and declined from Sep. 2023 (BDT336.1 Mil) to Dec. 2023 (BDT325.4 Mil).

Orion Infusions's annual Short-Term Debt increased from Jun. 2021 (BDT259.0 Mil) to Jun. 2022 (BDT292.5 Mil) and increased from Jun. 2022 (BDT292.5 Mil) to Jun. 2023 (BDT347.2 Mil).

Orion Infusions Short-Term Debt Historical Data

The historical data trend for Orion Infusions's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Orion Infusions Short-Term Debt Chart

Orion Infusions Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Short-Term Debt

Get a 7-Day Free Trial

314.42

306.02

258.99

292.54

347.22

Orion Infusions Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Short-Term Debt	Get a 7-Day Free Trial															305.70	303.74	347.22	336.08	325.43

Orion Infusions Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Orion Infusions Short-Term Debt Related Terms

Thank you for viewing the detailed overview of Orion Infusions's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Orion Infusions (DHA:ORIONINFU) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Orion Infusions Ltd (DHA:ORIONINFU) » Definitions » Short-Term Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

Tejgaon Industrial Area, No. 153-154, Dhaka, BGD, 1208

Website

https://www.orioninfusion.com

Orion Infusions Ltd is a pharmaceutical company. It produces various types of intravenous fluids, rehydration solutions, electrolyte solutions, antimicrobial products, and other pharmaceutical products in Bangladesh. The products of the company include Dextrolac, Dextropac, Dextrosal, Dianak, Electro dex, fructose, Hartman, Intralipid, Manisol, Maprocin, Nidazyl, Orlev, Ortac, Plasmasol, Proliv, and Salpac. In addition, the company is also involved in activities related to cosmetics and toiletries, infrastructure development, real estate and construction, power, agro products, hospitality, textiles and garments, and aviation management sectors. Geographically, it operates in Bangladesh.

Orion Infusions (DHA:ORIONINFU) Headlines

No Headlines